Clinical trials

  • LIV001 for Ulcerative colitis
  • Pembrolizumab for Metastatic uveal melanoma
  • APIXABAN for Intrahepatic non-cirrhotic portal hypertension|Non-cirrhotic portal hypertension
  • SGT-003 (human microdystrophin) for Duchenne muscular dystrophy
  • SIROLIMUS for Cutaneous sarcoidosis
  • NIVOLUMAB for B-cell acute lymphoblastic leukaemia (B-ALL)|Relapsed or refractory B-ALL
  • MK-1084 for Non-small cell lung cancer (non-squamous) | KRAS G12C-mutant non-small cell lung cancer
  • CEFTAZIDIME for Sepsis | Gram-negative sepsis
  • FREXALIMAB for Multiple sclerosis
  • Levetiracetam for Refractory focal-onset epilepsy | Drug-resistant focal onset seizures
  • JNJ-90189892 for Acute myeloid leukemia (relapsed or refractory) | Myelodysplastic syndrome (higher-risk, relapsed or refractory)
  • BASIMGLURANT for Trigeminal neuralgia